Article
Systematic identification of context-dependent gene-essentiality in Glioblastoma: The GBM-CoDE platform
2025-01-29
Abstract excerpt
Glioblastoma (GBM) is a heterogeneous and aggressive brain tumour that is invariably fatal despite maximal treatment. Genetic or transcriptomic ‘biomarkers’ could be used to stratify patients for treatments, however, pairing biomarkers with appropriate therapeutic ‘targets’ is challenging. Consequently, therapeutics have not yet been optimised for specific GBM patient subsets. Here we integrate genome-wide CRISPR/...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b7511ad9-1d62-5818-8e16-48c3812e0f33
- DOI
- 10.1101/2025.01.27.634260
